• Mashup Score: 0

    Light chain cast nephropathy (LCCN) is a leading cause of acute kidney injury (AKI) in patients with multiple myeloma (MM) and is now defined as a myeloma defining event. While the long-term prognosis has improved with novel agents, short-term mortality remains significantly higher in patients with LCCN especially if the renal failure is not reversed. Recovery of renal function requires a rapid…

    Tweet Tweets with this article
    • Multiple myeloma with acute light chain cast nephropathy [Mar 29, 2023] Leung & @VincentRK @BloodCancerJnl https://t.co/N67Knm0Ntv #mmsm #onconeph #neprhoonc

  • Mashup Score: 0
    Validate User - 3 year(s) ago

    We are sorry, but we are experiencing unusual traffic at this time. Please help us confirm that you are not a robot and we will take you to your content.

    Tweet Tweets with this article
    • Renal response in real-world carfilzomib- vs bortezomib-treated RRMM [Jan 19, 2021] @myelomaMD et al. @BloodAdvances https://t.co/wsDCtp9ZD9 #mmsm #onconeph #nephroonc RWE Kd > Vd in RRMM renal rescue & positive association b/w renal response & improved survival https://t.co/2RSvxu1bXn